BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36823341)

  • 1. A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio.
    Xu P; Wu D; Liu X
    Endocrine; 2023 Jul; 81(1):107-115. PubMed ID: 36823341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study.
    Prinzi A; Frasca F; Russo M; Le Moli R; Belfiore A; Malandrino P
    Endocr Pract; 2024 Mar; 30(3):194-199. PubMed ID: 38008257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
    Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
    Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.
    Prassas D; Kounnamas A; Cupisti K; Schott M; Knoefel WT; Krieg A
    Ann Surg Oncol; 2022 Apr; 29(4):2561-2569. PubMed ID: 34890024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.
    Luo Z; Hei H; Qin J; Zheng C; Gong W
    Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.
    Guo P; Wang X; Xia L; Shawureding N; Hu Z
    Cancer Med; 2023 Apr; 12(7):7868-7876. PubMed ID: 36560883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
    Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
    World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis.
    Jin S; Wang J; Shen Y; Gan H; Xu P; Wei Y; Wei J; Wu J; Wang B; Wang J; Yang C; Zhu Y; Ye D
    Int Urol Nephrol; 2020 Jan; 52(1):87-95. PubMed ID: 31552575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.